In summary, these findings demonstrate that PD-L1 positively regulates hTERT+-AM cell activity, thereby promoting tumor growth and recurrence, whereas its inhibition or downregulation through sgPD-L1 transfection or metformin treatment attenuates these aggressive phenotypes. Here, CD274 is linked to neoplasm.